首页 正文

Therapeutic strategies targeting complement in myasthenia gravis patients

{{output}}
Myasthenia gravis (MG) is an acquired autoimmune disorder characterized by impaired neuromuscular junction transmission, leading to fluctuating muscle weakness. With the progressive identification of MG-related antibodies, such as acetylcholine receptor (AChR)... ...